AI tool adoption is high and continues to climb. The survey shows most developers are now using AI assistants in their workflow or plan to soon, with daily and weekly use becoming routine. Trust is ...

Since 2008, Stack Overflow has been an immensely helpful resource for developers, allowing them to crowdsource answers to their coding questions — and resulting in a vast online repository of coding ...

Last month, Stack Overflow recorded just 3,862 questions. To put that in perspective, that is roughly the same volume the site saw during its launch month in 2008. At its peak around 2014, the ...

DEVCLASS also points out that Stack Overflow's focus on 'high-quality' questions is discouraging new users who want to ask casual questions. A 2025 survey by Stack Overflow found that 84% of ...

The latest trends in software development from the Computer Weekly Application Developer Network. This is a guest post for the Computer Weekly Developer Network written by Peter O’Connor, Senior ...

Stack Exchange Inc., the company behind the leading developer resource Stack Overflow, today announced the public launch of its new AI Assist feature. The company says it provides users with access to ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion Pharmaceuticals (RXRX) saw a sharp uptick in trading as investors looked ahead to the CEO's upcoming presentation at a major AI conference. The focus is on how the company’s AI strategy and ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

We recently published 10 Big Names With Explosive Growth. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best performers on Wednesday. Recursion Pharmaceuticals jumped by 16.44 percent on ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...